vitamin d kidney disease




It has been nicely established that secondary hyperparathyroidism begins comparatively early in the middle of continual kidney illness (CKD) and steadily progresses as GFR declines. The pathogenetic elements that contribute to the event and upkeep of secondary hyperparathyroidism are a number of however principally contain the carefully associated penalties of phosphate retention and abnormalities in vitamin D metabolism. In the midst of CKD, there’s a sluggish progressive lower within the ranges of 1,25-dihydroxyvitamin D (calcitriol) as kidney perform declines. The position of the reducing ranges of 1,25-dihydroxyvitamin D within the pathogenesis of secondary hyperparathyroidism is supported by the demonstration of the damaging results of 1,25-dihydroxyvitamin D on parathyroid hormone (PTH) gene transcription and the observations that administration of calcitriol can ameliorate the event of hyperparathyroidism and might successfully suppress the secretion of PTH when hyperparathyroidism has been established.

Vitamin D is both synthesized within the pores and skin or ingested within the weight loss plan and is transported to the liver, the place it’s hydroxylated within the 25 place to yield 25-hydroxyvitamin D, which is the principle storage type of vitamin D and the vitamin D metabolite to be measured to evaluate vitamin D diet. 25-Hydroxyvitamin D is additional hydroxylated by the enzyme 1-α-hydroxylase within the kidney, to yield 1,25-dihyroxyvitamin D, which is the energetic type of vitamin D, the key endocrine type of vitamin D, and this metabolite is answerable for the results of vitamin D on calcium and phosphorus metabolism, bone well being, and the regulation of parathyroid perform.

Lately, it has been demonstrated that many tissues not solely categorical the vitamin D receptor (VDR) but additionally could possess 1-α-hydroxylase and are due to this fact able to the manufacturing of 1, 25-dihydroxyvitamin D, which can act regionally. Such tissues embrace the prostate; the colon; the breast; macrophages; and cells of the vasculature, pancreas, and doubtlessly different websites. The position of this extrarenal 1-α-hydroxylase, with the manufacturing of 1,25-dihydroxyvitamin D in these tissues, isn’t nicely understood, however a wide range of in vitro research point out that this course of could also be concerned within the regulation of cell development and differentiation (1).


Mechanisms of Altered Vitamin D Metabolism in Kidney Illness

There appear to be a number of mechanisms concerned within the decreased ranges of 1,25-dihydroxyvitamin D that happen in the middle of kidney illness (Determine 1). Thus, a lower in renal mass will clearly restrict the portions of 1-α-hydroxylase which can be accessible for manufacturing of the energetic vitamin D metabolite. A discount in GFR could restrict supply of substrate to the 1-α-hydroxylase, which can additionally restrict the flexibility of the kidney to provide 1,25-dihydroxyvitamin D. The significance of a declining GFR in limiting the flexibility of the kidney to provide 1 to 25-dihydroxyvitamin D was illustrated by the work of Nykjaer et al. (2–6), who demonstrated that glomerular filtration of 25-hydroxyvitamin D, certain to vitamin D–binding protein, undergoes glomerular filtration and uptake into the proximal tubule cell by the receptor megalin and was the rate-limiting step within the supply of 25-hydroxyvitamin D to the 1-α-hydroxylase enzyme. Accordingly, as GFR declines, there’s a limitation of substrate supply that may compromise the flexibility of the failing kidney to provide 1,25-dihydroxyvitamin D (7). This can be compounded by the decreased ranges of 25-hydroxyvitamin D that appear to be widespread in sufferers with kidney illness (vide infra).

The latest discovery that fibroblast development factor-23 (FGF-23), which will increase in the middle of kidney illness, can straight suppress 1-α-hydroxylase could also be a further contributing issue that limits the flexibility of the failing kidney to keep up ranges of 1,25-dihyroxyvitamin D as kidney illness progresses. Shimada et al. (8) demonstrated that FGF-23 might lower the degrees of 1,25-dihydroxyvitamin D and reduce mRNA for 1-α-hydroxylase. Perwad et al. (9) additionally confirmed that FGF-23 induced a dosage-dependent lower in 1-α-hydroxylase mRNA. As well as, the exercise of 1-α-hydroxylase could also be straight suppressed by phosphate retention and hyperphosphatemia (1). An extra issue which may be concerned is the potential for N-terminally truncated PTH fragments or C-terminal PTH fragments to lower exercise of 1-α-hydroxylase (10).


Vitamin D Deficiency in CKD

Current observations have demonstrated that kidney illness appears to be related to a excessive incidence of vitamin D insufficiency or deficiency (11). Research by Gonzalez et al. (12) demonstrated that 25-hydroxyvitamin D values are <30 ng/ml, believed be the decrease restrict of regular, within the majority of sufferers with CKD. Sufferers who're severely proteinuric have the bottom values. These investigators have proven that just about the entire secondary hyperparathyroidism that happens in the middle of CKD is related to 25-hydroxyvitamin D values which can be <30 ng/ml. It's attention-grabbing to notice that on this affected person group, there's a optimistic relationship between 25-hydroxyvitamin D ranges and 1, 25-dihydroxyvitamin D ranges, in distinction to what's seen in regular people. Thus, when 25-hydroxyvitamin D ranges are elevated by remedy, one would anticipate a rise within the ranges within the 1,25-dihydroxyvitamin D. It isn't clear whether or not this can be a contribution of renal 1-α-hydroxylase or the 1-α-hydroxylase at extrarenal websites; nevertheless, due to the affiliation of low ranges of 25-hydroxyvitamin D with hyperparathyroidism in the middle of CKD, it is strongly recommended that in sufferers with CKD, if hyperparathyroidism is detected, then 25-hydroxyvitamin D must be measured, and if discovered to be <30 ng/ml, then the preliminary step within the remedy must be to attempt to appropriate this abnormality, as step one within the management of hyperparathyroidism.  

Results of Remedy with Ergocalciferol – “vitamin d kidney disease”

Zisman et al. (13) evaluated the present therapeutic tips to lift 25-hydroxyvitamin D by the administration of ergocalciferol. These investigators confirmed that in 52 sufferers with phases 3 and 4 CKD, the focus of 25-hydroxyvitamin D may very well be raised barely above 30 ng/ml, and such remedy was related to a comparatively small lower within the ranges of intact PTH, solely within the sufferers with stage 3 CKD and never in these with stage 4 CKD. Chandra et al. (14) evaluated cholecalciferol remedy, 50,000 U/wk for 12 wk, in a randomized, managed trial of phases 3 and 4 CKD and efficiently raised the geometric imply worth for 25-hydroxyvitamin D to nearly 50 ng/ml and confirmed a 31% lower in PTH within the handled group in contrast with 7% lower within the placebo group, however this was NS due to excessive variability in PTH values.

Research by Al-Aly et al. (15) had been comparable in design to the research of Zisman et al. (13), though the conclusions are considerably totally different and should make clear the outcomes of Chandra et al. (14). These investigators confirmed that solely roughly 50% of sufferers with CKD efficiently incremented the degrees of 25-hydroxyvitamin D in response to the usual remedy regimens, whereas the rest didn’t increment the degrees of 25-hydroxyvitamin D. It’s attention-grabbing that in sufferers who did enhance their ranges of 25-hydroxyvitamin D, PTH ranges declined, whereas PTH ranges didn’t change considerably in sufferers who didn’t reply. Related findings had been additionally demonstrated in sufferers with stage 4 CKD. Accordingly, extra research should be carried out to grasp the explanations that 25-hydroxyvitamin D ranges weren’t efficiently incremented in half of the sufferers, to evaluate the efficacy of this maneuver on the management of hyperparathyroidism.

This subject assumes explicit significance in mild of the observations that the administration of energetic vitamin D remedy to sufferers who’re on dialysis appears to be related to a survival benefit, in contrast with sufferers who didn’t obtain any vitamin D (16). These observations are confirmed by different investigators, together with Younger et al. (17), utilizing the Dialysis Outcomes and Observe Patterns Research (DOPPS) database, and Kalantar-Zadeh et al. (18) in a distinct cohort of sufferers, elevating the necessity to perceive the mechanisms concerned on this obvious survival profit related to vitamin D remedy. In these research, evidently this obvious survival profit is seen no matter calcium, phosphorus, or the degrees of PTH, suggesting that this can be an impact of vitamin D that’s unbiased of the results of vitamin D on bone and mineral metabolism. These observations have additionally been additional prolonged to vitamin D analogs; the analog paricalcitol has been proven to have an improved survival benefit over the native vitamin D sterol calcitriol (19). Equally, 1-α-hydroxyvitamin D2 has additionally been related to an obvious improved survival benefit over the native hormone calcitriol (20). Once more, in these research, the obvious survival profit appears to be unbiased of ranges of calcium, phosphorus, or PTH. Accordingly, it appears necessary to grasp the potential mechanisms concerned on this obvious survival profit, with the target that this may be doubtlessly exploited to enhance survival on this affected person group.

London et al. (21) evaluated 52 sufferers who had been on hemodialysis in a cross-sectional research for doable relationships of aortic stiffness, brachial artery distensibility, and arterial calcification scores with 25(OH)D3 and 1,25(OH)2D3 serum ranges. These investigators famous that these values had been negatively correlated with aortic pulse wave velocity and positively correlated with brachial artery distensibility and flow-mediated dilation. Whether or not vitamin D supplementation will enhance arteriosclerosis and endothelial dysfunction in sufferers who’re on hemodialysis must be additional evaluated sooner or later (21).

As a result of there appears to be solely a single VDR, it’s obscure how vitamin D analogs could differ from the impact of the native hormone, however this certainly appears to be the case. In research in vitro in vascular easy muscle cells, calcitriol appears to be a development issue for vascular easy muscle cells, whereas the analog, paricalcitol, isn’t (22). Moreover, in research in experimental animals in vivo, vitamin D sterols appear to have a distinct impact on vascular calcification, in that 1-α-hydroxyvitamin D2 or calcitriol appears to be related to better vascular calcification than is seen with paricalcitol, regardless of equal suppression of PTH in these animal fashions (23). Related research have been reported by Wu-Wong et al. (24,25), and different investigators have proven comparable leads to research of calcitriol, in contrast with 22-oxacalcitriol (26). Additional research are clearly wanted to grasp the potential mechanisms concerned for these differential results.

The pleiotropic results of vitamin D past the management of parathyroid perform or mineral metabolism could lengthen to different potential areas in the middle of CKD. Thus, in the middle of scientific research with oral paricalcitol for management of hyperparathyroidism in CKD, it was famous that sufferers who obtained paricalcitol appeared to have a discount in proteinuria, even sufferers who had been handled with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (27). In these research, Agarwal et al. (27) demonstrated that the antiproteinuric impact of oral paricalcitol in CKD was proven by a discount in proteinuria in 29 (51%) of 57 within the paricalcitol group in contrast with 15 (25%) of 61 within the placebo group with a P = 0.004. This was no matter age, gender, race, diabetes, hypertension, or use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors.

These observations increase the chance or the consideration that paricalcitol remedy could also be related to or could have the potential to change the development of CKD. Some proof exists to help this risk. Thus, whereas the position of the renin-angiotensin system (RAS) has been nicely described within the development of kidney illness, the vitamin D system has been proven to be concerned within the regulation of the RAS by Li et al. (28). In experimental circumstances, there’s proof that vitamin D remedy could favorably have an effect on the development of CKD. Thus, there are information to point out that glomerulosclerosis could also be decreased in a mannequin of five-sixths nephrectomy (29). The involvement of the VDR within the suppression of the RAS and the discount in glomerular development, cell differentiation, and fibrosis is doubtlessly essential within the mechanism of CKD development. Related results have additionally been proven in fashions of glomerulonephritis, and in extra research, results on the extensively identified elements which were recognized to have an effect on the development of kidney illness, comparable to podocyte hypertrophy (30), expression of TGF-β (31,32), expression of monocyte chemoattractant protein-1 (33,34), and the invasion of the remnant kidneys with macrophage-like cells, all have been proven to be doubtlessly modified by vitamin D remedy, such that there’s potential for this to have an effect on the development of kidney illness (35). As well as, Zhang et al. (36) confirmed that diabetic VDR knockout mice developed extra extreme albuminuria and glomerulosclerosis and expressed extra fibronectin and fewer nephrin in contrast with diabetic wild-type animals. In vitro, 1,25-dihydroxyvitamin D inhibited glucose-induced fibronectin manufacturing in mesangial cells and elevated nephrin in podocytes. Thus, vitamin D has the potential to have a positive impression in diabetic nephropathy. All of those experimental observations should be addressed and examined in sufferers, and research are in progress or in improvement to check this concept straight.

Vitamin D can also have an effect on the myocardium straight and play a job within the regulation of myocyte hypertrophy (37). Bodyak et al. (38) confirmed that paricalcitol attenuates left ventricular abnormalities in Dahl salt-sensitive hypertensive rats. Thus, it’s attention-grabbing to take a position that such results of vitamin D on the RAS or on the center could doubtlessly have an effect on cardiovascular occasions which can be a standard explanation for loss of life on this affected person group.


Suggestions for Vitamin D Remedy within the Course of CKD

An inexpensive method to the remedy of problems of bone and mineral metabolism in CKD, on the premise of present Kidney Illness Outcomes High quality Initiative (KDOQI) tips and scientific and experimental information, are proposed in Determine 2. Future tips could modify this method as they grow to be accessible and extra information are obtained, such because the forthcoming Kidney Illness: Bettering World Outcomes (KDIGO) tips.

Disturbances in bone and mineral metabolism must be evaluated early in the middle of CKD by the measurement of intact PTH, and interventions must be undertaken utilizing a “stepped care” method as illustrated in Determine 2 (39). Thus, in stage 2 or 3 CKD, if PTH is elevated, then vitamin D standing must be evaluated by measurement of 25-hydroxyvitamin D, and if <30 ng/ml, then treatment should be undertaken according to current practice guidelines, which recommend the administration of a vitamin D preparation such as ergocalciferol in sufficient dosage to raise 25-hydroxyvitamin D levels >30 ng/ml. Vitamin D, as both D3 or D2, doesn’t have important biologic exercise and have to be metabolized throughout the physique to the hormonally energetic type 1,25 dihydroxyvitamin D. The distinction between ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) with regard to the diploma of response of 25-hydroxyvitamin D ranges has not been studied in comparative trials in sufferers with CKD.

Dietary restriction of phosphorus could also be utilized in early CKD to help within the management of the growing hyperparathyroidism, though protein restriction must be modest to keep away from malnutrition. Different measures which were proven to achieve success embrace calcium supplementation and the usage of phosphate binders and the usage of vitamin D sterols comparable to calcitriol (40), the vitamin D prohormones alfacalcidol (41) and doxercalciferol (42), and the vitamin D analog paricalcitol (43). In superior kidney illness, the usage of energetic vitamin D sterols is extraordinarily efficient within the management of hyperparathyroidism (Desk 1). The vitamin D prohormones 1-α-hydroxyvitamin D3 and 1-α-hydroxyvitamin D2 bear 25-hydroxylation within the liver and grow to be 1 to 25-dihydroxyvitamin D3 and 1 to 25-dihydroxyvitamin D2, respectively. Vitamin D analogs are the energetic vitamin D molecules with facet chain modification or A hoop alterations which were launched with a objective of suppression of PTH whereas minimizing the results on calcium and phosphorus ranges. Three such analogs have been launched: 19-nor-1,25-dihydroxyvitamin D2 (44), 22-oxacalcitriol (45), and 26,27-hexafluorocalcitriol (46). 19-Nor-1,25-dihydroxyvitamin D2 is extensively utilized in america and has been efficient with considerably lesser toxicity than the native sterol calcitriol (47). The oral type can be utilized in phases 3 and 4 CKD (43). There aren’t any comparative research of the totally different vitamin D analogs with regard to security and efficacy in sufferers with CKD.

Additional research are required concerning the significance of remedy with vitamin D sterols in the middle of CKD in view of latest observations by Wolf et al. (48). These investigators examined the correlation of vitamin D ranges and early mortality in a retrospective cohort cross-sectional evaluation of 825 incident hemodialysis inhabitants. The crew measured the blood stage of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D at baseline, and 90-d mortality was evaluated. A complete of 78% of the affected person inhabitants was vitamin D poor, and 18% had been severely poor, and low ranges of 25-hydroxyvitamin D had been related to elevated mortality (48). Intervention with energetic vitamin D gave the impression to be related to improved final result. These necessary outcomes will want affirmation and extension by randomized, placebo-controlled trials, and extra research will probably be wanted to guage the results of vitamin D sterols on the development of kidney illness.



In-depth analysis prior to now 20 years has uncovered lots of the potential mechanisms wherein vitamin D is concerned within the initiation and upkeep of the disturbances of bone and mineral metabolism within the CKD inhabitants. This has been reproduced in bench and bedside scientific observations. The at the moment accessible therapeutic methods for vitamin D deficiency are necessary past the administration and management of the issues of disturbed mineral metabolism. Additional scientific analysis is required to reply questions together with such points because the optimum time to display for vitamin D deficiency regardless of PTH ranges; the results of remedy of vitamin D deficiency and insufficiency, maybe regardless of PTH ranges; potential variations between vitamin D2 and D3 sterols; and research to outline the optimum dosage, period, objectives, and outcomes of remedy of vitamin D deficiency.


Leave a Comment